Stay updated on Novel Therapeutics for High-Risk AML Clinical Trial
Sign up to get notified when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.

Latest updates to the Novel Therapeutics for High-Risk AML Clinical Trial page
- Check3 days agoChange DetectedVersion 3.6.5 was added on 2026-08-05, introducing updates to the Study Status and Contacts/Locations sections. The history also records **Revision: v3.6.5** and removes the prior **Revision: v3.6.4** entry.SummaryDifference0.2%

- Check11 days agoChange DetectedThe latest version updates the study title to 'Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)' and adds key sections (Contacts/Locations, Eligibility, Study Status, Study Identification). It also removes the previous title entry from 2026-07-16.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This reflects a platform-level update to the page rather than a modification to study content or history data.SummaryDifference0.0%

- Check25 days agoChange DetectedThe history adds entries for Contacts/Locations and Study Status on 2026-07-16, and an enrollment figure of 250 appears on 2026-07-15. These additions reflect updated administrative details and the trial's current status.SummaryDifference0.1%

- Check39 days agoChange DetectedThe latest version adds Contacts/Locations and Study Status to the version history, and updates the revision tag to v3.6.3. This reflects an enhanced display of historical attributes on the study record history page.SummaryDifference0.1%

- Check47 days agoChange DetectedA new revision entry (v3.6.2) was added to replace the previous v3.6.0, and the history now includes explicit labels for Contacts/Locations and Study Status in the version history.SummaryDifference0.2%

Stay in the know with updates to Novel Therapeutics for High-Risk AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.